VACCINEX, INC. (VCNX)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Annual

0 250K 500K 750K FY23: 570K FY24: 601K FY23 FY24

Gross Profit Annual

0 250K 500K 750K FY19: 324K FY20: 623K FY19 FY20

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income Annual

-24M -16M -8M 0 8M 16M 24M FY23: -22.9M FY24: -18.7M FY23 FY24

Net Income Annual

-21M -14M -7M 0 7M 14M 21M FY23: -20.3M FY24: -18.6M FY23 FY24

Cost of Revenue Annual

0 70K 140K 210K FY19: 199K FY20: 2K FY19 FY20

Operating Cash Flow Annual

-24M -16M -8M 0 8M 16M 24M FY23: -21.4M FY24: -16.2M FY23 FY24

Free Cash Flow Annual

-24M -16M -8M 0 8M 16M 24M FY23: -21.4M FY24: -16.2M FY23 FY24

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 800K 1.6M 2.4M FY23: 463.7K FY24: 2.1M FY23 FY24

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-180.00 -120.00 -60.00 0.00 60.00 120.00 180.00 Q1 '23: -115.40 Q2 '23: -139.81 Q3 '23: -153.39 Q4 '23: -43.68 Q1 '24: -25.73 Q2 '24: -4.29 Q3 '24: 8.13 Q4 '24: -8.90 Q1 '23 Q2 '23 Q3 '23 Q4 '23 Q1 '24 Q2 '24 Q3 '24 Q4 '24

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.